Project Grant R21AA030617
- The University of California, San Diego (UCSD) was awarded a $414,750 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to investigate the role of intestinal gp130 signaling in preventing alcohol-associated liver disease. The proposed research aims to define the gp130-STAT3-Reg3 signaling axis involved in protecting against ethanol-induced liver disease and assess the potential of a novel engineered gp130...
- The Project Grant award of $131,654 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding the development of a Lactobacillus-vectored alkaline phosphatase (AP) to mitigate alcohol-induced leaky gut and lipopolysaccharide (LPS) endotoxin load in the gut. The project aims to apply a two-pronged approach using: 1) Lactobacillus-based drug delivery technology to prevent alcohol-induced gut leakiness, and 2) the delivery of...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $253,383 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Yale University to explore the role of the hepatocyte inflammasome in alcoholic liver disease (ALD). This research aims to investigate the liver-specific effects of the inflammasome, a key mediator of inflammation, in hepatocytes - the predominant liver cell type and a driver of ALD pathophysiology. The project will use mouse models to evaluate...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $808,866 to Progenra Inc., a biotechnology firm located in Malvern, Pennsylvania. The funding supports research to evaluate novel small molecule compounds that activate the ubiquitin proteasome system (UPS) as potential therapeutics for treating acute and chronic pancreatitis. Key objectives include assessing...
- This Project Grant award of $303,737.00 from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) to the University of Florida supports research to investigate the impact of chronic alcohol consumption on the development and progression of Alzheimer's disease (AD). The key objectives of this 2-year award, running from May 1, 2025 to April 30, 2027, are to: 1) assess the influence of chronic ethanol exposure on metabolic function and tau pathology in...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
- This Project Grant award of $123,045.00 from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) supports research on the role of the TRAF3IP2 protein in the development of alcohol-related cardiomyopathy. The project will investigate whether alcohol-induced cardiac fibroblast activation, proinflammatory cytokine expression, and extracellular matrix changes are dependent on TRAF3IP2, and whether deleting the TRAF3IP2 gene prevents alcohol-induced...
- This federal Project Grant award of $396,643 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) supports research to elucidate the mechanisms underlying stress-potentiated ethanol drinking. The project aims to investigate the role of the histone methyltransferase G9a and its effects on dynorphin-positive neurons in the nucleus accumbens to regulate this behavior. Key objectives include testing the hypothesis that G9a's effects on...
- This federal Project Grant award of $3,182,397.00 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to the University of California, San Diego (UCSD). The grant aims to characterize the role of host gut proteases, particularly cathepsin B, and the immune response in alcohol-associated liver disease (ALD) in both a human cohort and a mouse model. The research seeks to determine how alcohol-mediated induction of...
- This Project Grant award of $147,486 from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) will support research at the University of Pittsburgh to investigate the role of metabotropic glutamate receptor 5 (mGlu5) signaling in regulating synaptic transmission and plasticity onto prefrontal cortex parvalbumin-expressing interneurons (PFC PV-INs) following chronic ethanol drinking. The research will utilize ex vivo slice electrophysiology,...
NOVEL MECHANISMS OF REGULATING ENDOPLASMIC RETICULUM HOMEOSTASIS IN ALCOHOLIC PANCREATITIS - PROJECT SUMMARY ALCOHOL ABUSE IS A MAJOR RISK FACTOR IN INITIATING PANCREATITIS IN HUMANS AND IN RODENTS. HOWEVER, ONLY LESS THAN 10% OF HEAVY DRINKERS DEVELOP ALCOHOLIC PANCREATITIS WHEREAS MOST HEAVY DRINKERS HAVE MILD AND AUTOLIMITED PATHOLOGICAL CHANGES, SUGGESTING THAT A REFINED ADAPTATION IN PANCREATIC CELLS TO PROTECT AGAINST THE DETRIMENTAL EFFECTS OF ALCOHOL. PANCREATIC EXOCRINE ACINAR CELLS POSSESS HIGH PROTEIN SYNTHETIC RATES TO PRODUCE AND SECRETE LARGE AMOUNTS OF DIGESTIVE ENZYMES. TO MEET THE HIGH DEMAND OF PROTEIN SYNTHESIS, ACINAR CELLS ARE EXCEPTIONALLY ENRICHED WITH ENDOPLASMIC RETICULUM (ER). DYSREGULATION OF ER HOMEOSTASIS CAN LEAD TO ER STRESS AND ACINAR CELL DAMAGE RESULTING IN THE ONSET OF PANCREATITIS. CELLS USE PROTECTIVE MECHANISMS SUCH AS AUTOPHAGY TO BALANCE THE HOMEOSTASIS OF ORGANELLES SUCH AS ER TO ADAPT AND PROTECT THEMSELVES FROM ER STRESS. DEFECTIVE BASAL AUTOPHAGY IN MOUSE PANCREAS DISRUPTS ER HOMOEOSTASIS RESULTING IN ER STRESS AND SPONTANEOUS PANCREATITIS. WE RECENTLY DEMONSTRATED THAT TRANSCRIPTION FACTOR EB (TFEB) DIRECTLY REGULATES LYSOSOMAL BIOGENESIS AND, INDIRECTLY, AUTOPHAGY, WHICH IS IMPAIRED BY ALCOHOL CAUSING ALCOHOLIC HEPATITIS AND PANCREATITIS. OUR PRELIMINARY STUDIES SHOWED THAT ALCOHOL FEEDING DECREASED VMP1 (VACUOLE MEMBRANE PROTEIN 1), AN ER-RESIDENT MULTISPANNING TRANSMEMBRANE PROTEIN, AT BOTH MRNA AND PROTEIN LEVELS IN AN EXPERIMENTAL ALCOHOL PANCREATITIS MOUSE MODEL. MORE IMPORTANTLY, ACINAR CELL-SPECIFIC DELETION OF VMP1 IN MICE LEADS TO INCREASED ER STRESS AND SPONTANEOUS PANCREATITIS. DAMAGED AND EXCESS ER CAN BE REMOVED VIA SELECTIVE AUTOPHAGY, TERMED AS ER-PHAGY, WHICH HELPS TO MAINTAIN ER HOMEOSTASIS AND RELIEVE ER STRESS. OUR LONG- TERM GOAL OF THIS PROPOSAL IS TO UNDERSTAND THE MOLECULAR MECHANISMS FOR HOW ALCOHOL DECREASES VMP1 IN ACINAR CELLS AND HOW VMP1-MEDIATED AUTOPHAGY PROTECTS AGAINST ALCOHOL-INDUCED PANCREATITIS. THE OBJECTIVE OF THIS PROPOSAL IS TO UNDERSTAND HOW VMP1-MEDIATED ER-PHAGY IS IMPAIRED BY ALCOHOL IN ACINAR CELLS AND HOW TO PHARMACOLOGICALLY MAINTAIN ACINAR CELL ER HOMEOSTASIS TO PROTECT AGAINST ALCOHOL-INDUCED PANCREATITIS. WE WILL DETERMINE HOW GENETIC AND PHARMACOLOGICAL ACTIVATION OF TFEB-VMP1-MEDIATED ER-PHAGY REGULATES ER HOMEOSTASIS AND PROTECTS AGAINST ALCOHOL-INDUCED PANCREATITIS. THIS PROPOSAL WILL ESTABLISH A FOUNDATION FOR THE DEVELOPMENT OF NOVEL THERAPEUTICS FOR TREATING ALCOHOLIC PANCREATITIS THROUGH MODULATION OF VMP1-MEDIATED ER-PHAGY TO MAINTAIN ACINAR CELL ORGANELLE HOMEOSTASIS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/19/25 | ||
| Not listed | $406.9k | 8/15/23 |